VRL is the first organ/tissue/eye donor screening laboratory to implement the Procleix Panther System (Grifols) for Nucleic Acid Testing (NAT), as FDA approval for use in the United States was recently announced. This presentation will focus on (i) platform changes (ii) NAT assay changes and (iii) the ability to test for several emerging infectious diseases. We will share our testing observations post-implementation.